GeneInCell

Vinod Reddy Lekkala
  • 0.0（0則評分）
  • 生命科學
  • 每週更新

GeneInCell-The AI-powered Biotech Podcast focuses on crisp, science-based podcasts on stem cells, organoids, and gene editing—tracking breakthroughs from bench to bedside for better human health, including Biotech and business.

  1. 7月27日

    Anti-Aging Peptides- Can We Slow the Biology of Aging? | GeneInCell | 2026

    Can peptides help slow the biological processes of aging? In this episode, we explore how anti-aging peptides may influence cellular repair, inflammation, metabolism, collagen production, and tissue regeneration. We examine the scientific evidence, emerging therapeutic applications, and the limitations and safety concerns surrounding peptide-based approaches to healthier aging.

    Anti-Aging Peptides- Can We Slow the Biology of Aging? | GeneInCell | 2026

  2. 7月13日

    The Cellular Clock: Telomerase and the Science of Slowing Aging | Longevity | GeneInCell

    Telomerase helps protect the ends of chromosomes, but its role in aging is complex. In this episode, we explore how telomeres influence cellular lifespan, whether activating telomerase could slow age-related decline, and the scientific and safety challenges that stand between promising research and future anti-aging therapies.

    The Cellular Clock: Telomerase and the Science of Slowing Aging | Longevity | GeneInCell

  3. 6月28日

    Can Epigenetic Reprogramming Reverse Aging? | GeneInCell | 2026

    Epigenetic reprogramming is emerging as one of the most intriguing ideas in aging research—the possibility that aging is not just damage, but also a reversible loss of cellular identity. In this episode, we explore how scientists are trying to reset the epigenetic instructions that control gene expression, tissue function, and biological age. We break down the science behind partial reprogramming, what preclinical studies suggest about rejuvenation, regeneration, and lifespan-related outcomes, and why safety, durability, and cancer risk remain major challenges. Can aging really be reversed, or are we only beginning to understand the code that drives it?

    Can Epigenetic Reprogramming Reverse Aging? | GeneInCell | 2026

  4. 6月22日

    Chemical Antibodies: How Aptamers Could Transform Future Therapies | GeneInCell | 2026

    Aptamers are emerging as powerful “chemical antibodies” that can bind targets with high precision while offering advantages in design, synthesis, and stability. In this episode, we explore how these short nucleic acid ligands are selected, how they work, and why they are gaining attention as next-generation tools for diagnostics, targeted delivery, and therapy. We also discuss their potential to reshape future medicine, along with the key challenges that must be solved for broader clinical use.

    Chemical Antibodies: How Aptamers Could Transform Future Therapies | GeneInCell | 2026

  5. 6月15日

    Antisense Oligonucleotides: Programming RNA to Silence Disease | GeneInCell | 2026

    Antisense oligonucleotides are redefining medicine by programming RNA to silence disease at its source. In this episode, we explore how these short, sequence-designed molecules bind target RNA to reduce harmful protein production, reshape splicing, and open new possibilities for precision therapeutics. We cover the history, mechanism, chemistry, and growing clinical relevance of ASOs, along with their promise and limitations in treating genetic, neurological, retinal, muscular, liver, and rare diseases.

    Antisense Oligonucleotides: Programming RNA to Silence Disease | GeneInCell | 2026

  6. 5月30日

    Silencing Genetic Disease with shRNA | GeneInCell | 2026

    shRNA is a gene-silencing tool that uses the cell’s own RNA interference machinery to reduce harmful protein production. In this episode, we explore how short hairpin RNAs are designed to target specific mutant genes, how they are delivered into cells, and why they hold promise for treating genetic disease through long-lasting gene knockdown.

    Silencing Genetic Disease with shRNA | GeneInCell | 2026

  7. 5月24日

    Base Editing- Rewriting DNA One Letter at a Time | GeneInCell | 2026

    Base editing is changing the future of gene editing by allowing scientists to rewrite DNA one letter at a time. In this episode, we explore how base editors work, why they offer a more precise alternative to traditional CRISPR cutting, and how they are being used to correct disease-causing mutations. We also look at their growing potential in research and medicine, along with the challenges that remain for safe and effective clinical use.

    Base Editing- Rewriting DNA One Letter at a Time | GeneInCell | 2026

  8. 5月16日

    siRNAs: Programmable Drugs for Silencing Genetic Disease | GeneInCell

    siRNAs are transforming medicine by acting as programmable drugs that selectively silence disease-causing genes. In this episode, we explore how small interfering RNAs work through the RNA interference pathway, why they are so powerful for precision therapeutics, and how they are being developed to treat genetic, metabolic, liver, and rare diseases. We also discuss delivery challenges, clinical progress, and what makes siRNA one of the most promising platforms in modern drug development.

    siRNAs: Programmable Drugs for Silencing Genetic Disease | GeneInCell
顯示全部 (39)

簡介

GeneInCell-The AI-powered Biotech Podcast focuses on crisp, science-based podcasts on stem cells, organoids, and gene editing—tracking breakthroughs from bench to bedside for better human health, including Biotech and business.

資訊

  • 創作者
    Vinod Reddy Lekkala
  • 活躍年代
    2025年 - 2026年
  • 集數
    39
  • 年齡分級
    兒少適宜
  • 版權
    © Vinod Reddy Lekkala
  • 節目網站
    GeneInCell